Zhongsheng Tianxinhe (Wuxi) Biotechnology Co., Ltd., a service provider and supplier of biopharmaceutical process technology and solutions, focuses on improving the independent and controllable capabilities of China's upstream raw materials and equipment, and accelerating the development of the biopharmaceutical industry. Tianxinhe focuses on the research and production of personalized cell culture media, bioreactor process design and manufacturing, large-scale animal cell culture process technology research, and development and transfer of biological process technology. Based on this, it has constructed the biopharmaceutical process technology technology. Development platform.

Tianxinhe (Suzhou) Biotechnology Co., Ltd. is a wholly-owned subsidiary of Zhongsheng Tianxinhe (Wuxi) Biotechnology Co., Ltd. It covers a total area of ​​8,000 square meters in Wujiang, Suzhou, and has built a 5,000 square meters of cell culture medium that meets GMP requirements. Workshop, bioreactor production workshop and R&D laboratory. The company has passed the ISO9001:2015 quality management system and ISO14001:2015 environmental management system certification. The annual output of cell culture medium reaches 150 tons, and the annual output of bioreactors is more than 50 sets, which can meet the dynamic needs of the development of the biopharmaceutical industry such as antibodies and vaccines. .